Indication

Acute promyelocytic leukemia

Acute promyelocytic leukemia is an aggressive subtype of acute myeloid leukemia characterized by an abnormal accumulation of immature granulocyte precursors, known as promyelocytes, within the bone marrow and peripheral blood. Read more about Acute promyelocytic leukemia

50 drugs 38 manufacturers

Advertisement

Drugs that treat it

Common Acute promyelocytic leukemia therapies.

Showing 10–18 of 50 drugs

TRETINOIN

ANTINEOPLASTIC - TRETINOIN·ACUTE PROMYELOCYTIC LEUKEMIA
PAR HEALTH USA,
Filter & compare in the drug finder →Opens the drug finder with Acute promyelocytic leukemia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Acute promyelocytic leukemia.

Acute promyelocytic leukemia is an aggressive subtype of acute myeloid leukemia characterized by an abnormal accumulation of immature granulocyte precursors, known as promyelocytes, within the bone marrow and peripheral blood.

Affecting both adults and children, it is primarily driven by a balanced reciprocal translocation between chromosomes 15 and 17, creating the pathognomonic PML-RARA fusion oncogene that arrests normal myeloid cell differentiation.

Patients typically present with manifestations of cytopenias—such as fatigue, infection, and marked pallor—alongside a severe, life-threatening coagulopathy marked by disseminated intravascular coagulation, hyperfibrinolysis, and catastrophic bleeding risks.

Personalize your experience

Follow Acute promyelocytic leukemia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it